Ladenburg analyst Aydin Huseynov initiated coverage of PMV Pharmaceuticals with a Buy rating and $7 price target.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on PMVP:
- PMV Pharmaceuticals reports Q3 EPS (34c), consensus (45c)
- PMV Pharmaceuticals Reports Third Quarter 2023 Financial Results and Corporate Highlights
Questions or Comments about the article? Write to editor@tipranks.com